Search Results - "LINAHAN, B. M"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Phase I trial of cremophor EL with bolus doxorubicin by MILLWARD, M. J, WEBSTER, L. K, RISCHIN, D, STOKES, K. H, TONER, G. C, BISHOP, J. F, OLVER, I. N, LINAHAN, B. M, LINSENMEYER, M. E, WOODCOCK, D. M

    Published in Clinical cancer research (01-10-1998)
    “…Cremophor EL (cremophor), a component of the paclitaxel formulation, can potentially reverse P-glycoprotein-associated multidrug resistance. A Phase I trial of…”
    Get full text
    Journal Article
  2. 2

    Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of Paclitaxel by Rischin, Danny, Webster, Lorraine K., Millward, Michael J., Linahan, Bernadette M., Toner, Guy C., Woollett, Anne M., Morton, Carmel G., Bishop, James F.

    “…Background Paclitaxel (Taxol) is a new drug with efficacy against a variety of malignant tumors. The clinical formulation of paclitaxel contains 50% Cremophor…”
    Get full text
    Journal Article
  3. 3

    In vitro antitumour activity of some triorganophosphinegold(i) thionucleobases by Tiekink, E R, Cookson, P D, Linahan, B M, Webster, L K

    Published in Metal-based drugs (1994)
    “…A series of phosphinegold(I) thionucleobase analogues, [R(3)PAu(SR(x))] (R = Et, Ph or chexyl; HSR(1) = 2-mercaptobenzoic acid, HSR(2) = 2-thiouracil, HSR(3) =…”
    Get full text
    Journal Article